Malinda Ingram
Nurse Practitioner · Tupelo, MSNPI 1245276849
Payments from drug & device makers
Across 75 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$273
- Astellas Pharma US Inc$259
- Mayne Pharma Commercial LLC$150
- Bayer$105
- W. L. Gore & Associates, Inc.$100
- Lilly USA, LLC$82
- plus $552 from 13 others
What the payments were for
- Food & beverage$1,520100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $273 |
| Astellas Pharma US Inc | 12 | $259 |
| Mayne Pharma Commercial LLC | 6 | $150 |
| Bayer | 5 | $105 |
| W. L. Gore & Associates, Inc. | 1 | $100 |
| Lilly USA, LLC | 6 | $82 |
| Boehringer Ingelheim | 1 | $75 |
| Novo Nordisk | 5 | $71 |
| Bausch Health US, LLC | 4 | $69 |
| Amgen | 4 | $62 |
| Millicent US Inc | 3 | $47 |
| Shield Therapeutics Inc | 2 | $37 |
| Exeltis, USA Inc. | 2 | $35 |
| AstraZeneca | 2 | $35 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Hologic Sales And Service, LLC | 1 | $32 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Intuitive Surgical | 1 | $20 |
| Organon | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,520 in reported general payments places this provider in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 57 | $3,694 |
| Metronidazole | 37 | $1,436 |
| Olanzapine | 21 | $418 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $327 |
| Atorvastatin Calcium | 25 | $282 |
| Fluconazole | 24 | $252 |
| ValacyclovirValacyclovir Hcl | 14 | $179 |
| Nystatin | 23 | $178 |
| Gabapentin | 11 | $175 |
| Omeprazole | 17 | $159 |
| Buspirone Hcl | 12 | $109 |
| Donepezil Hcl | 16 | $106 |
| Tamsulosin Hcl | 11 | $93 |
| Medroxyprogesterone Acetate | 12 | $74 |
| Amlodipine Besylate | 13 | $26 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCOlanzapine | $82 | $41821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,090 nurse practitioner providers in Mississippi.
Other nurse practitioner in Tupelo
- Katelyn BorenTupelo$10K
- Stephanie AtkinsonTupelo$7K
- Meagan HillhouseTupelo$7K
- Janice DriskellTupelo$6K
- Christina TreppendahlRidgeland$673K
- Catherine WellsJackson$75K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
- Micaela PerkinsOxford$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.